Evidence map›Paper›PMID 25958130›Full record

ArticleJournal of virological methods2015

A novel flow cytometry-based tool for determining the efficiency of human cytomegalovirus infection in THP-1 derived macrophages.

Huifen Li, Genxiang Mao, Joshua Carlson, Sean X Leng

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Huifen LiDivision of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA.
Genxiang MaoZhejiang Provincial Key Lab of Geriatrics, Zhejiang Hospital, Hangzhou, Zhejiang Province, China.
Joshua CarlsonDivision of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA.
Sean X LengDivision of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA. Electronic address: sleng1@jhmi.edu.
Johns Hopkins University · USZhejiang Hospital · CN

Funding

Influenza vaccine failure in adults over age 75: role of chronic CMV infectionR01AI108907 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LENG, SEAN XIAO · 2014 to 2018
$2.8M
Chronic CMV infection in the elderly: diagnosis and link to chronic inflammationR21AG043874 · NIA · JOHNS HOPKINS UNIVERSITY · PI LENG, SEAN XIAO · 2013 to 2014
$446k
NIAID NIH HHS R01 AI108907NIAID NIH HHS R01-AI-108907NIA NIH HHS R21 AG043874NIA NIH HHS R21-AG-043874
6 · The paper itself

Abstract

Human cytomegalovirus (hCMV) is a ubiquitous pathogen that causes congenital infection and severe infections in immunocompromised patients. Chronic hCMV infection may also play an important role in immunosenescence and adverse health outcomes in older adults. THP-1, a human monocytic cell line and its derived macrophages serve as a useful cell culture model for mechanistic studies of hCMV infection and its underlying biology. A major methodological challenge is the lack of a quick and reliable tool to accurately determine the efficiency of hCMV infection in THP-1 derived macrophages. In this study, we developed a flow cytometry based method using commercially available monoclonal antibody (MAb) against hCMV immediate early (IE) antigen that can accurately determine infection efficiency. We used 0.5% formaldehyde for fixation, 90% methanol for permeabilization, and incubation with FITC conjugated MAb at 37°C. The method was tested by hCMV infection with laboratory Towne strain in the presence or absence of hydrocortisone. It was also compared with the routine flow cytometry protocol using Cytofix/Cytoperm solution and with immunofluorescence. The results indicate that this new method is reliable and time saving for accurate determination of infection efficiency. It may facilitate further investigations into the underlying biological mechanisms of hCMV infection.

Indexed as

AgedAged, 80 and overAntibodies, MonoclonalAntibodies, ViralAntigens, ViralCell LineCytomegalovirusFlow CytometryFluorescent Antibody TechniqueHumansMacrophagesVirologyAntibodies, MonoclonalAntibodies, ViralAntigens, ViralFlow cytometryhCMVInfection efficiencyTHP-1

Identifiers

PMID25958130
PMCPMC5960983
OpenAlexW771232395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.